NWI Management’s Ambrx Biopharma Inc AMAM Stock Holding History

NWI Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-53,645	Closed	-$764K	–	57
2023 Q4	$764K	Sell	53,645 -107,290	-67%	-$1.22M	0.02%	49
2023 Q3	$1.85M	Buy	+160,935	New	+$2.19M	0.09%	39

NWI Management's AMAM Position: Q1 2024 in Review

NWI Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 53,645 shares — an estimated $764K sold.

NWI Management first reported a position in AMAM in Q3 2023 and held it in 2 quarters. The position peaked at $1.85M in Q3 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

NWI Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
NWI Management sold 53,645 Ambrx Biopharma Inc shares in Q1 2024, an estimated $764K.
NWI Management first reported a position in Ambrx Biopharma Inc in Q3 2023 and held it in 2 quarters.
NWI Management's Ambrx Biopharma Inc position peaked at $1.85M in Q3 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on NWI Management's 13F filing for Q1 2024, filed 15 May 2024.